Abstract
Bariatric surgery patients represent a diverse group of individuals often with multiple coexisting medical problems. Nephrolithiasis has been shown to occur at variable rates relative to the specific procedure that individuals have undergone. The following chapter discusses stone risk factors, biochemical changes, and treatment strategies available for postoperative bariatric surgery patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BMI:
-
Body mass index
- BPD/DS:
-
Biliopancreatic diversion with duodenal switch
- CaOx:
-
Calcium oxalate GI Gastrointestinal
- LAGB:
-
Laparoscopic adjustable gastric banding
- PCC:
-
Potassium citrate and calcium citrate
- RYGB:
-
Laparoscopic Roux-en-Y gastric bypass
- SG:
-
Laparoscopic sleeve gastrectomy
- SS:
-
Supersaturation
References
Abegg K, Gehring N, Wagner CA, et al. Roux-en-Y gastric bypass surgery reduces bone mineral density and induces metabolic acidosis in rats. Am J Physiol Regul Integr Comp Physiol. 2013;305:R999–R1009.
Academy of Nutrition and Dietetics. Nutrition care manual. Kidney stones. https://www.nutritioncaremanual.org. Accessed 30 Sept 2016.
Agrawal V, Liu XJ, Campfield T, Romanelli J, Enrique Silva J, Braden GL. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2014;10(1):88–94.
ASMBS Clinical Issues Committee. Updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2012;8(3):E21–6.
Canales BK, Hatch M. Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies. Surg Obes Relat Dis. 2014;10(4):734–42.
CDC “Adult Obesity Prevalence Maps”. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 01 Sept. 2016. Web. 2 Nov 2016.
Estimate of Bariatric Surgery Numbers, 2011–2015 – American Society for Metabolic and Bariatric Surgery. American Society for Metabolic and Bariatric Surgery. American Society for Metabolic and Bariatric Surgery, 7/2016.
Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013;8:1389–95.
Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. 2009;28(5):w822–31. https://doi.org/10.1377/hlthaff.28.5.w822 originally published online July 27, 2009.
Froeder L, Arasaki CH, Malheiros CA, Baxmann AC, Heilberg IP. Response to dietary oxalate after bariatric surgery. Clin J Am Soc Nephrol. 2012;7:2033–40.
Han H, Segal AM, Seifter JL, Dwyer JT. Nutritional management of kidney stones (Nephrolithiasis). Clin Nutr Res. 2015;4(3):137–52. https://doi.org/10.7762/cnr.2015.4.3.137.
Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int. 2006;69(4):691–8.
Home HP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59:270–6.
Hoyer-Kuhn H, Kohbrok S, Volland R, Franklin J, Hero B, Beck BB, Hoppe B. Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice. Clin J Am Soc Nephrol. 2014;9(3):468.
Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, D.C.: National Academies Press; 2004.
Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington, D.C.: National Academies Press; 2005.
Kim J, Eisenberg D, Azagury D, Rogers A, Campos G. American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. Surg Obes Relat Dis. 2016;12(3):453–9.
Li F, Zhang G, Liang J, Ding X, Cheng Z, Hu S. Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats. J Gastrointest Surg. 2009;13(12):2302–8.
Lieske JC, Goldfarb DS, De Simone C, et al. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int. 2005;68(3):1244–9.
Matlaga BR, Shore AD, et al. Effect of gastric bypass on kidney stone disease. J Urol. 2009;181:2573–7. https://doi.org/10.1016/j.juro.2009.02.29.
Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, the Obesity Society, and the American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14(Suppl 1):1–83.
Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring, Md). 2013;21(1):S1–27. https://doi.org/10.1002/oby.20461.
National Center for Health Statistics. Health, United States, 2015: with special feature on racial and ethnic health disparities. Hyattsville: National Center for Health Statistics; 2016.
NIH. Gastrointestinal surgery for severe obesity. Consensus Statement. 1991;9(1):1–20.
Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011–2014. In: NCHS data brief, no 219. Hyattsville: National Center for Health Statistics; 2015.
Oliveira LM, Hauschild DB, Leite Cde M, Baptista DR, Carvalho M. Adequate dietary intake and nutritional status with nephrolithiasis: new targets and objectives. Ren Nutr. 2014;24(6):417–22. https://doi.org/10.1053/j.jrn.2014.06.003. Epub 2014 Aug 3.
Parrot J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13:727–41.
Pi-Sunyer FX, et al. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. J Am Diet Assoc. 1998;98(10):1178–91.
Robertson WG. Dietary recommendations and treatment of patients with recurrent idiopathic kidney calcium and stone disease. Urolithiasis. 2016;44:9–26. https://doi.org/10.1007/s00240-015-0849-2.
Sakhaee K, Pak C. Superior calcium bioavailability of effervescent potassium calcium citrate over tablet formulation of calcium citrate after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9:743–8.
Sakhaee K, Griffith C, Pak CY. Biochemical control of bone loss and stone-forming propensity by potassium-calcium citrate after bariatric surgery. Surg Obes Relat Dis. 2012;8:67–72.
Shah S, Calle JC. Dietary management of recurrent nephrolithiasis. Cleve Clin J Med. 2016;83(6):463–71. https://doi.org/10.3949/ccjm.83a.15089.
Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol. 2001;166(4):1487–91.
Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–62.
Valezi AC, Paulo E, Fuganti JM Jr, Delfino VD. Urinary evaluation after RYGBP: a lithogenic profile with early postoperative increase in the incidence of urolithiasis. Obes Surg. 2013;23(10):1575–80.
Williams HE, Wandzilak T. Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol. 1989;141:742–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Patient Case
Patient Case
-
HPI: 80-year-old man, former marine and retired airline pilot who presents to the clinic with complaints of 6/10 lower back pain that radiates to his right side and lower abdomen and one episode of vomiting with persistent nausea for the last 24 hours. He has been drinking mostly liquids since yesterday and took ibuprofen to relieve his pain however found that it continued.
-
Medical history: Hypertension, hyperlipidemia, obesity, single kidney stone in 2014 s/p lithotripsy, depression, migraine headaches, vitamin D deficiency.
-
Surgical history: RYGB.
-
Medications: Lisinopril, simvastatin, bupropion, sumatriptan, ibuprofen prn, complete multivitamin with iron once a day, vitamin B12 500 mcg a day, vitamin D 2000 units a day, calcium carbonate 400 mg a day.
Ht: 68” Wt: 206 lbs BMI: 31.4
24-hour dietary recall
-
Take medications regularly in morning and evening.
-
One cup regular coffee with cream, three cups decaf coffee w/cream.
-
8–10 oz. water.
-
5–6 saltine crackers.
-
Slice of toast with butter.
Eating habits
-
Eating frequency: three meals/day with occasional snack in the afternoon
-
Protein choices: poultry, beef, pork, eggs, and cheese. No longer using protein supplements
-
Eating out: 4–6×/week; pizza and salad, chicken parmesan with pasta and marinara sauce, 6 oz. steak with mashed potatoes and spinach, eggs with bacon, potatoes, and toast
-
Fluid intake: regular and decaf coffee with cream, occasional water, or juice. No alcohol or milk
The patient was sent for a CT scan after initial visit and was found to have a kidney stone. He underwent lithotripsy, and stone analysis showed calcium oxalate.
Looking back at CM’s history, what were some of his risk factors for stone development?
-
Hx RYGB with previous kidney stone.
-
Low fluid intake – Perhaps learned this as a pilot; drinking mostly coffee
-
Frequent meal out with likely high sodium and fat content, potential fat malabsorption
-
Inadequate calcium supplementation – 400 mg calcium carbonate vs 1200–1500 mg calcium citrate recommended
What lifestyle recommendations will you discuss with the patient?
-
Increase fluid intake to at least 2.5 liters a day, and devise a consistent hydration routine.
-
Reduce sodium intake to <2300 mg/day, more cooking at home.
-
Monitor oxalate content in foods and limit concentrated sources.
-
Consider decrease in animal protein sources and increase calcium-containing foods such as yogurt or whey protein supplement.
-
Change calcium carbonate to calcium citrate, and increase to 1200 mg a day; take with meals.
What medical evaluation and treatment recommendations will you discuss with the patient?
-
Obtain 24-hour urinary chemistry profile before dietary modification and 6 weeks after.
-
His baseline 24-hour urinary chemistry profile showed high urinary oxalate, low urinary citrate, high CaOx SS, and low urine volume.
-
Start potassium citrate 20 mEq three times a day if the patient continues to have low urinary citrate and high CaOx SS after initial dietary and lifestyle modification.
-
Repeat 24 urinary chemistry profile 4–8 weeks after initiating potassium citrate.
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Reece, J., Vosburg, R.W., Goyal, N. (2019). Bariatric Surgery and Stone Risk. In: Han, H., Mutter, W., Nasser, S. (eds) Nutritional and Medical Management of Kidney Stones. Nutrition and Health. Humana, Cham. https://doi.org/10.1007/978-3-030-15534-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-15534-6_15
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-15533-9
Online ISBN: 978-3-030-15534-6
eBook Packages: MedicineMedicine (R0)